Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer

por Konstantinopoulos, Panagiotis A., Matulonis, Ursula A.
Publicado 2013

PARP Inhibitor Resistance Mechanisms and Implications for Post-Progression Combination Therapies

por Lee, Elizabeth K., Matulonis, Ursula A.
Publicado 2020

POLE-mutated clear cell cervical cancer associated with in-utero diethylstilbestrol exposure

por Lee, Elizabeth K., Lindeman, Neal I., Matulonis, Ursula A., Konstantinopoulos, Panagiotis A.
Publicado 2019

Targeted Next-Generation Sequencing Reveals Clinically Actionable BRAF and ESR1 Mutations in Low-Grade Serous Ovarian Carcinoma

por Stover, Elizabeth H., Feltmate, Colleen, Berkowitz, Ross S., Lindeman, Neal I., Matulonis, Ursula A., Konstantinopoulos, Panagiotis A.
Publicado 2018

An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers

por Przybytkowski, Ewa, Davis, Thomas, Hosny, Abdelrahman, Eismann, Julia, Matulonis, Ursula A., Wulf, Gerburg M., Nabavi, Sheida
Publicado 2020

Deciphering serous ovarian carcinoma histopathology and platinum response by convolutional neural networks

por Yu, Kun-Hsing, Hu, Vincent, Wang, Feiran, Matulonis, Ursula A., Mutter, George L., Golden, Jeffrey A., Kohane, Isaac S.
Publicado 2020

Validation of an open-source smartphone step counting algorithm in clinical and non-clinical settings

por Straczkiewicz, Marcin, Keating, Nancy L., Thompson, Embree, Matulonis, Ursula A., Campos, Susana M., Wright, Alexi A., Onnela, Jukka-Pekka
Publicado 2023

Open-Source, Step-Counting Algorithm for Smartphone Data Collected in Clinical and Nonclinical Settings: Algorithm Development and Validation Study

por Straczkiewicz, Marcin, Keating, Nancy L, Thompson, Embree, Matulonis, Ursula A, Campos, Susana M, Wright, Alexi A, Onnela, Jukka-Pekka
Publicado 2023

FF-10850, a Novel Liposomal Topotecan Achieves Superior Antitumor Activity via Macrophage- and Ammonia-Mediated Payload Release in the Tumor Microenvironment

por Shimoyama, Susumu, Okada, Ken, Kimura, Toshifumi, Morohashi, Yasushi, Nakayama, Shinji, Kemmochi, Sayaka, Makita-Suzuki, Keiko, Matulonis, Ursula A., Mori, Mikinaga
Publicado 2023

Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer

por Penson, Richard T, Ambrosio, Allison J, Whalen, Christin A, Krasner, Carolyn N, Konstantinopoulos, Panagiotis A, Bradley, Charles, Matulonis, Ursula A, Birrer, Michael J
Publicado 2023

Safety and management of niraparib monotherapy in ovarian cancer clinical trials

por Monk, Bradley J, González-Martin, Antonio, Buckley, Lynn, Matulonis, Ursula A., Rimel, B J, Wu, Xiaohua, Moore, Kathleen N, Mirza, Mansoor R
Publicado 2023

High Throughput Interrogation of Somatic Mutations in High Grade Serous Cancer of the Ovary

por Matulonis, Ursula A., Hirsch, Michelle, Palescandolo, Emanuele, Kim, Eejung, Liu, Joyce, van Hummelen, Paul, MacConaill, Laura, Drapkin, Ronny, Hahn, William C.
Publicado 2011

Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells

por Choi, Young Eun, Battelli, Chiara, Watson, Jacqueline, Liu, Joyce, Curtis, Jennifer, Morse, Alexander N., Matulonis, Ursula A., Chowdhury, Dipanjan, Konstantinopoulos, Panagiotis A.
Publicado 2014

Genomic Determinants of De Novo Resistance to Immune Checkpoint Blockade in Mismatch Repair–Deficient Endometrial Cancer

por Gulhan, Doga C., Garcia, Elizabeth, Lee, Elizabeth K., Lindemann, Neal I., Liu, Joyce F., Matulonis, Ursula A., Park, Peter J., Konstantinopoulos, Panagiotis A.
Publicado 2020

Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer

por Lee, Elizabeth K., Tan-Wasielewski, Zhenying, Matulonis, Ursula A., Birrer, Michael J., Wright, Alexi A., Horowitz, Neil, Konstantinopoulos, Panagiotis A., Curtis, Jennifer, Liu, Joyce F.
Publicado 2019

Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib

por Eismann, Julia, Heng, Yujing J., Waldschmidt, Johannes M., Vlachos, Ioannis S., Gray, Kathryn P., Matulonis, Ursula A., Konstantinopoulos, Panagiotis A., Murphy, Charles J., Nabavi, Sheida, Wulf, Gerburg M.
Publicado 2019

Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the F...

por Martin, Lainie P., Konner, Jason A., Moore, Kathleen N., Seward, Shelly M., Matulonis, Ursula A., Perez, Raymond P., Su, Ying, Berkenblit, Anna, Ruiz-Soto, Rodrigo, Birrer, Michael J.
Publicado 2017

COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies

por Monk, Bradley J., Coleman, Robert L., Moore, Kathleen N., Herzog, Thomas J., Secord, Angeles Alvarez, Matulonis, Ursula A., Slomovitz, Brian M., Guntupalli, Saketh R., O'Malley, David M.
Publicado 2020

Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations

por Birkbak, Nicolai Juul, Kochupurakkal, Bose, Izarzugaza, Jose M. G., Eklund, Aron C., Li, Yang, Liu, Joyce, Szallasi, Zoltan, Matulonis, Ursula A., Richardson, Andrea L., Iglehart, J. Dirk, Wang, Zhigang C.
Publicado 2013

BRAF and AXL oncogenes drive RIPK3 expression loss in cancer

por Najafov, Ayaz, Zervantonakis, Ioannis K., Mookhtiar, Adnan K., Greninger, Patricia, March, Ryan J., Egan, Regina K., Luu, Hoang Son, Stover, Daniel G., Matulonis, Ursula A., Benes, Cyril H., Yuan, Junying
Publicado 2018